139 related articles for article (PubMed ID: 1450608)
1. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging.
Ceballos-Picot I; Nicole A; Sinet PM
EXS; 1992; 62():89-98. PubMed ID: 1450608
[TBL] [Abstract][Full Text] [Related]
2. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
Ceballos-Picot I
C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
[TBL] [Abstract][Full Text] [Related]
3. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of copper-zinc superoxide dismutase in trisomy 21.
De La Torre R; Casado A; López-Fernández E; Carrascosa D; Ramírez V; Sáez J
Experientia; 1996 Sep; 52(9):871-3. PubMed ID: 8841514
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase.
Ceballos-Picot I; Nicole A; Clément M; Bourre JM; Sinet PM
Mutat Res; 1992 Sep; 275(3-6):281-93. PubMed ID: 1383770
[TBL] [Abstract][Full Text] [Related]
7. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.
Minc-Golomb D; Knobler H; Groner Y
EMBO J; 1991 Aug; 10(8):2119-24. PubMed ID: 1829676
[TBL] [Abstract][Full Text] [Related]
8. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
[TBL] [Abstract][Full Text] [Related]
9. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
Ceballos I; Nicole A; Briand P; Grimber G; Delacourte A; Flament S; Blouin JL; Thevenin M; Kamoun P; Sinet PM
Free Radic Res Commun; 1991; 12-13 Pt 2():581-9. PubMed ID: 1829430
[TBL] [Abstract][Full Text] [Related]
10. The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome.
Brugge KL; Nichols S; Delis D; Saitoh T; Truaner D
EXS; 1992; 62():190-8. PubMed ID: 1450586
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth.
Zhang Y; Zhao W; Zhang HJ; Domann FE; Oberley LW
Cancer Res; 2002 Feb; 62(4):1205-12. PubMed ID: 11861405
[TBL] [Abstract][Full Text] [Related]
12. Expression of manganese superoxide dismutase is not altered in transgenic mice with elevated level of copper-zinc superoxide dismutase.
White CW; Nguyen DH; Suzuki K; Taniguchi N; Rusakow LS; Avraham KB; Groner Y
Free Radic Biol Med; 1993 Dec; 15(6):629-36. PubMed ID: 8138189
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene.
Barkats M; Bertholet JY; Venault P; Ceballos-Picot I; Nicole A; Phillips J; Moutier R; Roubertoux P; Sinet PM; Cohen-Salmon C
Neurosci Lett; 1993 Sep; 160(1):24-8. PubMed ID: 8247326
[TBL] [Abstract][Full Text] [Related]
14. Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome.
Yarom R; Sapoznikov D; Havivi Y; Avraham KB; Schickler M; Groner Y
J Neurol Sci; 1988 Dec; 88(1-3):41-53. PubMed ID: 2976083
[TBL] [Abstract][Full Text] [Related]
15. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome.
Peled-Kamar M; Lotem J; Okon E; Sachs L; Groner Y
EMBO J; 1995 Oct; 14(20):4985-93. PubMed ID: 7588627
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
[TBL] [Abstract][Full Text] [Related]
17. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
[TBL] [Abstract][Full Text] [Related]
18. Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in transgenic, transfected, and trisomic cells.
Huang TT; Carlson EJ; Leadon SA; Epstein CJ
FASEB J; 1992 Feb; 6(3):903-10. PubMed ID: 1740238
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice.
Huang TT; Carlson EJ; Gillespie AM; Shi Y; Epstein CJ
J Gerontol A Biol Sci Med Sci; 2000 Jan; 55(1):B5-9. PubMed ID: 10719757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
